Best treatments for diabetic nephropathies
13 products may treat diabetic nephropathies, spanning FDA drug classes such as angiotensin 2 receptor blocker, angiotensin converting enzyme inhibitor. The current highest-rated option is micardis. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 13 drugs we list for diabetic nephropathies, 12 are available as lower-cost generics, spanning classes such as angiotensin 2 receptor blocker, angiotensin converting enzyme inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for diabetic nephropathies — so confirm the right choice with your prescriber.
Understanding diabetic nephropathies
"Diabetic nephropathies" is the medical index term for kidney damage caused by diabetes — the category most people search for as diabetic kidney disease. MedlinePlus (NLM) puts it plainly: "Kidney damage from diabetes is called diabetic nephropathy," and states that diabetes is the most common cause of kidney failure in the United States. NIDDK reports that about 1 out of 3 adults with diabetes has kidney disease. The thing people get wrong is that they wait to feel it. According to NIDDK, "Most people with diabetic kidney disease do not have symptoms. The only way to know if you have diabetic kidney disease is to get your kidneys checked." That check is two tests — a urine albumin-to-creatinine ratio (UACR) and an estimated glomerular filtration rate (eGFR) from blood. The ADA's Standards of Care in Diabetes—2026 (Section 11) says to assess both at least annually in people with type 1 diabetes of ≥5 years' duration and in all people with type 2 diabetes, regardless of treatment. A normal urine albumin result does not clear you: the ADA notes that reduced eGFR without albuminuria is frequently reported in both type 1 and type 2 diabetes. The ADA also uses UACR 30–299 mg/g creatinine as moderately increased albuminuria and ≥300 mg/g as severely increased — the numbers that change what gets prescribed. This is general information, not medical advice; decisions about your kidneys and your medicines belong with your own clinician.
First-line treatment
The American Diabetes Association's Standards of Care in Diabetes—2026 (Section 11, Chronic Kidney Disease and Risk Management) frames treatment around drug classes, not a single drug. In nonpregnant people with diabetes and hypertension, an ACE inhibitor or an angiotensin receptor blocker (ARB) is recommended at moderately increased albuminuria (UACR 30–299 mg/g) and strongly recommended at UACR ≥300 mg/g and/or eGFR <60. For type 2 diabetes with CKD, the ADA recommends an SGLT2 inhibitor with demonstrated benefit, and a GLP-1 receptor agonist with demonstrated benefit, to slow CKD progression and reduce cardiovascular risk; finerenone is identified as the only nonsteroidal mineralocorticoid receptor antagonist with proven kidney and cardiovascular benefits. Counterintuitively, the ADA does not recommend an ACE inhibitor or ARB for primary prevention when blood pressure, UACR, and eGFR are all normal.
Top-rated picks for diabetic nephropathies: 1. Micardis · 2. Atacand · 3. Avapro
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Tablet | Angiotensin 2 Receptor Blocker | Generic | $5 | View → | |
| 2 | 70/100 | Prescription | Tablet | Angiotensin 2 Receptor Blocker | Generic | $16 | View → | |
| 3 | 70/100 | Prescription | Tablet | Angiotensin 2 Receptor Blocker | Generic | $3 | View → | |
| 4 | 70/100 | Prescription | Tablet | Angiotensin 2 Receptor Blocker | Generic | $2 | View → | |
| 5 | 70/100 | Prescription | Solution | Angiotensin Converting Enzyme Inhibitor | Generic | $0 | View → | |
| 6 | 70/100 | Prescription | Solution | Angiotensin Converting Enzyme Inhibitor | Generic | $1 | View → | |
| 7 | 70/100 | Prescription | Tablet | Angiotensin 2 Receptor Blocker | Generic | $4 | View → | |
| 8 | 66/100 | Prescription | Tablet | Angiotensin 2 Receptor Blocker | Generic | $3 | View → | |
| 9 | Not yet rated | Prescription | Suspension | Angiotensin 2 Receptor Blocker | Generic | $1 | View → | |
| 10 | Not yet rated | Prescription | Tablet | Angiotensin Converting Enzyme Inhibitor | Generic | $2 | View → |
Narrow by drug class
Explore the class hubs: angiotensin 2 receptor blocker · angiotensin converting enzyme inhibitor
Full ranking · 13 treatments
micardis
PrescriptionFDA-sourced
Micardis (Telmisartan) is an angiotensin 2 receptor blocker used to treat Diabetic Nephropathies, Heart Failure, Hypertension, Left Ventricular Dysfunction.
Pharmacy pays
From ~$3.15/30· 3 forms Save up to 78% in classatacand
Boxed warningPrescriptionFDA-sourced
Atacand (Candesartan Cilexetil) is an angiotensin 2 receptor blocker used to treat Diabetic Nephropathies, Heart Failure, Hypertension, Left Ventricular Dysfunction.
Pharmacy pays
From ~$14.66/30· 4 forms Save up to 94% in class
avapro
Boxed warningPrescriptionFDA-sourced
Avapro (Irbesartan) is an angiotensin 2 receptor blocker used to treat Diabetic Nephropathies, Hypertension, Left Ventricular Dysfunction.
Pharmacy pays
From ~$2.45/30· 3 forms Save up to 70% in classbenicar
Boxed warningPrescriptionFDA-sourced
Benicar (Olmesartan Medoxomil) is an angiotensin 2 receptor blocker used to treat Diabetic Nephropathies, Heart Failure, Hypertension, Left Ventricular Dysfunction.
Pharmacy pays
From ~$1.73/30· 3 forms Save up to 55% in classepaned
Boxed warningPrescriptionFDA-sourced
Epaned (Enalapril Maleate) is an angiotensin converting enzyme inhibitor used to treat Rheumatoid Arthritis, Bartter Syndrome, Diabetic Nephropathies, Edema.
Pharmacy pays
From ~$0.07· 5 formsqbrelis
Boxed warningPrescriptionFDA-sourced
Qbrelis (Lisinopril) is an angiotensin converting enzyme inhibitor used to treat Diabetic Nephropathies, Heart Failure, Hypertension, Myocardial Infarction.
Pharmacy pays
From ~$0.43/30· 6 formsFrequently asked
- What treats diabetic nephropathies?
- Our catalog lists 13 products that may treat diabetic nephropathies, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is micardis.
- What is the best-rated treatment for diabetic nephropathies?
- By our independent recall-safety rating — not an efficacy measure — micardis ranks highest among the products we list for diabetic nephropathies. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat diabetic nephropathies?
- Treatments for diabetic nephropathies span FDA drug classes including angiotensin 2 receptor blocker, angiotensin converting enzyme inhibitor. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Sources
The clinical overview above is written from these authoritative public-health and medical-society sources, independently reviewed against each.